Wednesday, July 18, 2012

Missed Sleep May Contribute to Asthma Morbidity

Missed sleep may contribute to asthma morbidity in urban children, according to a study published in the July issue of the Annals of Allergy, Asthma & Immunology...

Keep reading at: doctorslounge.com



Cairns-based asthma cure drug trial receives US funding

CAIRNS scientists who created a ground-breaking drug that cures asthma in mice have received financial backing from a US pharmaceutical giant to further develop it for human trials...

Read full story at cairns.com.au



Synapse Develops Technology for Innovative Asthma Management Device

SEATTLE, July 17, 2012 /PRNewswire via COMTEX/ -- Asthmapolis, a Wisconsin-based company dedicated to advancements in asthma treatment, partnered with Synapse to develop breakthrough technologies for asthma treatment. Combining medication sensors, mobile applications, and analytics, the Asthmapolis sensor attaches to existing rescue inhalers to collect data such as when and where patients experience asthma conditions. Having recently received U.S. Food and Drug Administration clearance, Asthmapolis will soon begin marketing the technology to healthcare providers for their patients with asthma and chronic obstructive pulmonary disease (COPD)...

Read more here: marketwatch.com

No comments: